Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart

This publication has 20 references indexed in Scilit:

• Aspirin to Prevent Heart Attack and Stroke: What’s the Right Dose?
  The American Journal of Medicine, 2006
• Low-Dose Aspirin for the Prevention of Atherothrombosis
  New England Journal of Medicine, 2005
• Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution
  Prostaglandins, Leukotrienes & Essential Fatty Acids, 2005
• The role of aspirin-triggered lipoxins in the mechanism of action of aspirin
  Prostaglandins, Leukotrienes & Essential Fatty Acids, 2005
• 15-epi-lipoxin A4–mediated Induction of Nitric Oxide Explains How Aspirin Inhibits Acute Inflammation
  The Journal of Experimental Medicine, 2004
• Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa
  Proceedings of the National Academy of Sciences, 2003
• Relative contribution of acetylated cyclooxygenase (COX)‐2 and 5‐lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin
  The FASEB Journal, 2003
• Stereospecificity of Hydrogen Abstraction in the Conversion of Arachidonic Acid to 15R-HETE by Aspirin-treated Cyclooxygenase-2
  Journal of Biological Chemistry, 2000
• Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate
  Proceedings of the National Academy of Sciences, 1999
• Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions.
  Proceedings of the National Academy of Sciences, 1995